Abstract: The present invention discloses a coal mine multi-disaster fusion early warning method and system, applicable in coal mine safety disaster analysis. First, it builds a model and relationship network among multi-disaster early warning entities, updating the network by specific rules. A trend prediction model using an LSTM artificial neural network is then developed for monitoring object trends, along with natural fission analysis rules. Next, a method for identifying anomalies in single disaster events is established through a disaster index prediction and early warning system. Upon detecting an anomaly in an early warning index, other disaster indexes are assessed using a depth-first traversal algorithm and natural fission rules, facilitating targeted forecasting. This invention builds a predictive relationship chain among early warning indexes through correlation analysis, providing advantages in multi-dimensional analysis and advanced trend prediction.

Abstract: Isolated compounds from Adelostemma gracillimum refined fractions and compositions containing the compounds are provided by the present invention. Adelostemma gracillimum refined fractions and the extraction process thereof are also provided by the present invention. The uses of the compounds and the Adelostemma gracillimum refined fractions for inhibiting the activities of NMDA receptor or amyloid-beta peptide, for improving memory, and for treating neurodegenerative diseases, neuropathological conditions or epilepsy are further provided by the present invention.

Abstract: Provided are water and alcohol extracts of Rhizoma arisaematis, compounds isolated from Rhizoma arisaematis (such as 3-O-(9,12-octadecadienoyl)-glyceryl-?-D-galactopyranoside, N-(?-D-ribofuranos-1-yl)-phenylalanine, and adenosine), pharmaceutical compositions comprising the aforementioned ingredients, as well as uses thereof for promoting wound healing. In one embodiment, the pharmaceutical composition is a topical formulation, such as a cream, ointment, foam, lotion, plaster, gel, and emulsion.

Abstract: Isolated compounds from adelostemma gracillimum refined fractions and compositions containing the compounds are provided by the present invention. Adelostemma gracillimum refined fractions and the extraction process thereof are also provided by the present invention. The uses of the compounds and the adelostemma gracillimum refined fractions for inhibiting the activities of NMDA receptor or amyloid-beta peptide, for improving memory, and for treating neurodegenerative diseases, neuropathological conditions or epilepsy are further provided by the present invention.